Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 1(6), p. e389-e389, 2016
DOI: 10.1038/bcj.2015.115
Links
- ORCID
- Springer Nature [academic journals on nature.com] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
Journal article published in 2016 by
A.-L. Gagez,
E. Tuaillon,
R. Cezar,
C. Dartigeas,
B. Mahé,
R. Letestu,
H. Maisonneuve,
V. Gouilleux Gruart,
K. Bollore,
E. Ferrant,
T. Aurran,
P. Feugier,
S. Leprêtre,
G. Cartron 
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 